Page last updated: 2024-08-18

4-phenylenediamine and Chronic Primary Open Angle Glaucoma

4-phenylenediamine has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abernathy, E; Alt, C; Arora, P; Bloch, KD; Brouckaert, P; Buys, ES; Clerté, M; de Waard, N; Giani, A; Gong, H; Gregory, MS; Hayton, SR; Jones, A; Kang, JH; Ko, YC; Ksander, BR; Lin, CP; Loomis, SJ; Malhotra, R; Nathan, D; Oh, DJ; Pasquale, LR; Ren, R; Rhee, DJ; Scherrer-Crosbie, M; Tainsh, LT; Tainsh, RE; Turcotte, R; Wiggs, JL; Yu, B1

Other Studies

1 other study(ies) available for 4-phenylenediamine and Chronic Primary Open Angle Glaucoma

ArticleYear
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Glaucoma, Open-Angle; Guanylate Cyclase; Immunohistochemistry; Intraocular Pressure; Mice; Mice, Knockout; Mice, Mutant Strains; Ophthalmoscopy; Optic Nerve; Phenylenediamines; Receptors, Cytoplasmic and Nuclear; Retinal Neurons; Soluble Guanylyl Cyclase; Tomography, Optical Coherence

2013